FDA

Avadel Pharmaceuticals (AVDL) is currently close winning regulatory approval for FT218, a controlled-release version of sodium oxybate, which is used to treat narcolepsy. Avadel Pharmaceuticals PLC (AVDL) is looking like a strong candidate for a long-term position. It has a number of elements that signal appreciation. These include: 1. Unusual options trading activity. 2 . […]